Compass Pathways
UK - CheshireBiotechnology
Focus: Compass Pathways is a UK-based biotechnology company specializing in psilocybin-assisted therapy for psychiatric disorders, positioned at the forefront of the psychedelic medicine renaissance. The company is advancing a pipeline focused on treatment-resistant depression, major depressive disorder, anorexia nervosa, and PTSD.
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
Open Jobs
116-2 this month
Stable — net -2 jobs in 30d
13 added, 15 removed. Backfill posture.
Should You Work at Compass Pathways?
AI assessmentBest fit for commercial-track professionals betting on psychedelic psychiatry becoming mainstream; riskier for R&D scientists or those seeking mature support functions.
Why Work Here
- Early-stage market opportunity in psychedelic psychiatry with major pharma attention (Lilly, J&J) validating the space as evidenced by recent news coverage.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Treatment Resistant DepressionClinical Trials (1)
NCT04519957Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
N/AHelp build intelligence for Compass Pathways
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.